Content about Par

February 24, 2012
Par completes acquisition of Edict

Generic drug maker Par Pharmaceutical has completed its acquisition of an Indian drug company, Par said.

August 24, 2011
Par to acquire Anchen

Par Pharmaceutical Cos. will acquire Anchen Pharmaceuticals for $410 million, Par said Wednesday.

August 3, 2011
Par reports second-quarter earnings

Par Pharmaceutical had sales of $224.2 million and profits of $9.05 million during second quarter 2011, the drug maker said Wednesday.

December 20, 2010
Strativa president announces exit

The president of Par Pharmaceutical's subsidiary announced his resignation on Monday.

© 2013 Drug Store News. All Rights Reserved.